Immune tolerance in patients with multiple sclerosis and neuromyelitis optica by peptide-loaded tolerogenic dendritic cells: Final results of the phase 1B clinical trial and extension

Authors
Category Primary study
JournalNeurology
Year 2019
This article has no abstract
Epistemonikos ID: 991bccfca4c77bd07cea31fee86fdeb524b18f89
First added on: Feb 11, 2025